/
How Can Precision Medicine in Oncology Refine Best Treatment Approach? How Can Precision Medicine in Oncology Refine Best Treatment Approach?

How Can Precision Medicine in Oncology Refine Best Treatment Approach? - PowerPoint Presentation

coveurit
coveurit . @coveurit
Follow
343 views
Uploaded On 2020-06-15

How Can Precision Medicine in Oncology Refine Best Treatment Approach? - PPT Presentation

Introduction How Has Precision Medicine Changed the Treatment Landscape in Oncology Selection of Biomarkers in Drug Development Methods to Identify Driver Mutations Which Method Should Be Used ID: 777458

testing ntrk medicine larotrectinib ntrk testing larotrectinib medicine treatment clinical precision trk targets tumors cancers methods development fusion trials

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "How Can Precision Medicine in Oncology R..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

How Can Precision Medicine in Oncology Refine Best Treatment Approach?

Slide2

Introduction

Slide3

How Has Precision Medicine Changed the Treatment Landscape in Oncology?

Slide4

Selection of Biomarkers in Drug Development

Slide5

Methods to Identify Driver Mutations

Slide6

Which Method Should Be Used?

Slide7

Challenges With Testing Methods in Precision Medicine

Slide8

Novel Targets: NTRK

Slide9

Novel Targets

Slide10

Estimated Frequency of TRK Fusions Varies Across Tumor Types

Slide11

Active Clinical Trials of TRK Inhibitors in Patients With NTRK Fusion Tumors

Slide12

Entrectinib Studies

Slide13

Best Response to Entrectinib in Patients With TKI Treatment-Naive Extracranial Solid Tumors

Slide14

Larotrectinib Basket Trials

Slide15

Clinical Efficacy of Larotrectinib in NTRK

Fusion Cancers

Slide16

Integrated Clinical Development of Larotrectinib Simultaneously Across Adult and Pediatric Cancers

Slide17

NTRK Testing Options

Slide18

Pan-TRK IHC Staining Concordance With RNA Testing

Slide19

Conclusions

Slide20